TheraSphere Glioblastoma Device

· Boston Scientific Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TheraSphere Glioblastoma Device, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM [Phase 1]

See pricing